Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,073 across all filing types
Latest filing 2025-10-31 Regulatory Filings
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - TT Electronics Plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more. This type of document is a specific regulatory disclosure required by the Takeover Panel and is distributed via a Regulatory Information Service (RNS). It does not fit into categories like Annual Reports, Earnings Releases, or M&A activity announcements (though it relates to an offer, it is a disclosure of holdings, not the M&A announcement itself). Therefore, it is classified as a Regulatory Filing (RNS).
2025-10-31 English
Form 8.3 - Mural Oncology plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, for Mural Oncology PLC). This type of regulatory disclosure regarding significant shareholdings and derivative positions during a takeover process is classified as a Major Shareholding Notification.
2025-10-30 English
Form 8.3 - Alpha Group International plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. This specific filing details positions and dealings in Alpha Group International PLC by Citadel Group. Since this is a mandatory regulatory disclosure regarding shareholdings and dealings during a takeover period, it falls under the category of Major Shareholding Notification (MRQ) as it relates to significant ownership and position disclosure.
2025-10-30 English
Form 8.3 - Avadel Pharmaceuticals plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' filed under the Irish Takeover Panel rules. This form is used for 'Opening Position Disclosure/Dealing Disclosure' by persons with interests in relevant securities representing 1% or more during a takeover or merger process. This falls under the category of 'Major Shareholding Notification' (MRQ) as it reports significant ownership and changes in holdings related to a specific offeror/offeree.
2025-10-30 English
Form 8.3 - Avadel Pharmaceuticals plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel rules. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, for Avadel Pharmaceuticals PLC). This type of regulatory disclosure regarding significant shareholding and dealing activity during a takeover process falls under the 'Major Shareholding Notification' category, as it tracks ownership thresholds and changes in interest.
2025-10-29 English
Form 8.3 - Mural Oncology plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel rules. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer. This falls under the category of 'Major Shareholding Notification' (MRQ) as it reports significant ownership levels and changes in interest related to a specific company (Mural Oncology PLC) during a takeover scenario.
2025-10-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.